2021/10/08 | University | Health & Medicine

“We must not displace patients from the center or care”

Claudio Bassetti, Dean of the Faculty of Medicine at the University of Bern, talks in an interview about the opportunities and challenges of digitalized medicine - and what lessons can be learned from the Corona pandemic for the medicine of the future.

Interview: Monika Kugemann

In its Strategy 2030, the Faculty of Medicine prioritizes digitalization. Why?
Claudio Bassetti: The university has earmarked digitalization and artificial intelligence as a priority. For the Faculty of Medicine, this is even more relevant because medicine is highly influenced by digitalization. There are so many areas that are now changing – from patient care in acute and in chronic diseases, to the planning and execution of complex surgical interventions and the electronic patient record, to teaching, research and even administrative aspects in healthcare. All of these areas are being accelerated by digitalization. 

The founding of the Center for Artificial Intelligence in Medicine CAIM at the Faculty of Medicine as a specialized center for research, development, and teaching in AI applications for healthcare is a clear statement of our intention to shape and promote this development. 

How is medicine being transformed by digitalization?
The Corona pandemic has made us more aware of the importance of digitalization in medicine: We need to make even greater use of digital opportunities, for example by enabling teleconsultations, i.e the provision of medical care without physical presence.

Telemonitoring was also very strongly promoted by Corona, the possibility of accompanying patients in the individual manifestation of their illness. This can be the evaluation of medical imaging at a distance, or include measurements of heart rhythm, temperature, breathing and oxygen saturation, but also sleep disturbances. Here we have learned through the pandemic how we can detect deteriorations early on, for example, when people who are ill are still at home and not yet in hospital. 

In addition, a large proportion of medical teaching is now taking place via digital media - also spurred by the pandemic. We are seeing that some educational topics can perhaps be conveyed better in this way than in a classic lecture hall setting. 

Where do you see the role of AI in this transformation?
Digitalization also means being able to integrate and assess a lot of data. Here, artificial intelligence can help aggregate large data volumes from different sources such as laboratory data, medical imaging, genetic analysis, tissue samples from biobanks, etc. and analyze them with regard to several variables. This is important in precision medicine to offer patients the best individual therapy.

Increasingly, we want to consider all this data together to better understand health and disease. And for this compilation of multi-source data (also referred to as Big Data), we need new analytical approaches, commonly summarized as Artificial Intelligence.

Where can AI-based technologies improve patient care?
Let me give you an example from my field, neurology, which is particularly topical right now: We recently inaugurated NeuroTec, a platform to research and develop novel, flexible and cost-efficient technologies to improve diagnostics, monitoring and therapy of neurological diseases. We are working especially in the areas of motor function (Parkinson's disease, epilepsy), sleep disorders and cognition (dementia, Alzheimer's disease). The goal is to be able to monitor patients at home over a longer time, e.g. by measuring their vital data with wearables (sensors worn on the body) or nearables (non-invasive sensors installed in the household).

NeuroTec has been deliberately created at the interface of medicine, digitalization, and AI: We want to live and actively shape this transformation. For this, we need digitalization and data processing methods such as artificial intelligence. That is why we have hired a professor Prof. Athina Tzovara, as part of an interfaculty research collaboration who will work on these AI aspects.

How important is interdisciplinarity in this context? 
Very important indeed! We need physicians to understand the disease, engineers to develop nearables and exploit them, physicists, mathematicians, IT specialists and industrial partners.

In Bern, we are very well positioned in this respect: One of our flagships at the university and the university hospital is translationality, i.e. the transfer of research results into practice. One of the reasons why we are strong in this area is that our bioengineers work in a very practice-oriented way thanks to their direct integration into the medical faculty and their good relationships with the Bern MedTech industry. This puts us in a very good position to take a big step towards improving patient care.

Do you also see caveats in the use of digitalization and AI in medicine?
I firmly believe that despite using all these methods, we must not displace patients from the center of care. Corona has taught us that personal interaction, regular contact and physical proximity are so important. In medicine, we cannot and do not want to completely replace this human interaction with digitalization.

Then, of course, data confidentiality is crucial. The Insel Gruppe has taken the necessary protective measures as part of its digitalization process to securely enable increased data evaluation through AI. These are two aspects that we must remain aware of.

What potential arises for the Bern Medical Hub and how will the university exploit it? 
On the one hand, we are seizing the opportunity to participate in this important transformation in close interaction with society, politics, and industry. On the other hand, this transformation enables us to attract talented researchers. By creating and filling several professorships associated with biomedicine, digitalization and AI, the university has made a clear commitment to invest in this area.

Bern, as a university with a holistic approach, is also committed to increasing interfaculty collaboration in this area. The Faculty of Medicine has therefore launched several joint projects with the Faculty of Science. And, of course, close cooperation with the University Hospital is essential.

Such collaborations across disciplinary boundaries are crucial to success. After all, innovation arises when people look beyond their own field of expertise. Corona has shown us: It is not science alone, but the alliance with politics – of scientific expertise with practical decision-making power – that is needed to solve societal challenges.

About Claudio Bassetti

Claudio Bassetti is Dean of the Faculty of Medicine of the University of Bern. He is Professor of Neurology and Director of the Department of Neurology at the University Hospital. 

Contact

Prof. Dr. med. Claudio L. Bassetti
Department of Neurology, Bern University Hospital / Faculty of Medicine, University of Bern
claudio.bassetti@insel.ch

CENTER FOR ARTIFICIAL INTELLIGENCE IN MEDICINE (CAIM)

The Center for Artificial Intelligence in Medicine is a research, teaching and translation platform for medical technology that uses AI to deliver better care to patients and facilitate the work of doctors and nurses. CAIM capitalizes on the unique constellation in Bern that joins players from the scientific, healthcare and industry domains. It will be inaugurated in January 2021 as a Center of the University of Bern’s medical faculty and the Inselspital, Bern University Hospital, with the University Psychiatry Services (UPD) and the Swiss Institute for Translational and Entrepreneurial Medicine, sitem-insel, as partners. Part of Bern’s initiative for digitalization in healthcare, CAIM is a virtual center connecting engineers, physicians and scientists in the area of AI in medicine and providing them with resources and access to infrastructure. By bundling transdisciplinary know-how from the Bern Biomedical Engineering Network, it promotes and expands projects dedicated to the potential of AI technology for healthcare. CAIM will foster commercialization of AI technology innovation, support start-up incubation and create sustained value through best in class research, translation and economic growth.

ABOUT THE AUTHOR

Monika Kugemann is Communications Lead of the ARTORG Center for Biomedical Engineering Research and Center for Artificial Intelligence in Medicine (CAIM) of the University of Bern.